Schedule 13G ownership disclosure
GLYCOMIMETICS INC
Common Stock, $0.001 par value · CUSIP: 38000Q102
Event date: 2024-08-09
- Filing-level shares
- 3,403,931.00
- Percent of class
- 5.3%
- Weinstein Benjamin
Shares: 3,403,931.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002033801-24-000002
- Form type
- SCHEDULE 13G
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Aug 14, 2024
- Reporting period
- Aug 09, 2024
- Description
- Schedule 13G beneficial ownership